Healthcare Utilization of Patients with Opioid Use Disorder in US Hospitals from 2016 to 2019: Focusing on Racial and Regional Variances

Kim, Sun Jung; Medina, Mar; Chang, J.C.S.

doi:10.1007/s40261-022-01192-0

Cited by 3 publications

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Alongside the surging overdose crisis in the United States, rates of hospitalization for opioid use disorder (OUD) have increased over three-fold since 1998 [ 12 ], with emerging evidence also noting dramatic increases in stimulant-related hospitalizations [ 13 , 14 ]. Weighted estimates from the National Inpatient Sample report 506,155 hospitalizations for OUD from 2016 to 2019 [ 15 ]. Despite the prevalence of PWUD in hospitals, many of these patients do not receive evidence-based SUD treatment during their hospitalization [ 16 ], resulting in poor outcomes.…”

Section: Introductionmentioning

confidence: 99%

“I wouldn’t need Narcan for myself, but I can have it for somebody else:” perceptions of harm reduction among hospitalized patients with OUD

French

Davis

Aronowitz

et al. 2023

Addict Sci Clin Pract

View full text Add to dashboard Cite

Background Extant literature is limited on adoption of evidence-based harm reduction strategies in hospitals. We explored patient perceptions of incorporating harm reduction supplies and education in hospital care with patients with opioid use disorder (OUD). Methods Qualitative descriptive study of hospitalized patients with OUD in Philadelphia, PA using semi-structured interviews conducted between April and August of 2022. Results Three major themes emerged from 21 interviews with hospitalized patients with OUD: (1) Applicability and Acceptability of Harm Reduction Practices for Oneself; (2) Applicability and Acceptability of Harm Reduction Practices for Others; (3) Perceptions of Harm Reduction Conversations. Most participants were familiar with harm reduction but varied in their perceptions of its relevance for their lives. We noted differences in how participants viewed the applicability and acceptably of harm reduction practices that they perceived as intended to help others (e.g., naloxone) versus intended to help themselves (e.g., syringes). Most participants reported that meaningful conversations about drug use did not happen with their care team but that these conversations would have been acceptable if they were conducted in a way consistent with their individual substance use goals. Conclusions Patients' interest and perceived acceptability of harm reduction services during hospitalization varied by individual patient factors and the perceived user of specific interventions. Given their positive potential, harm reduction practices should be incorporated in hospitals, but this must be done in a way that is acceptable to patients. Our findings reveal ways to integrate concepts from a harm reduction approach within a traditional medical model. More work is needed to understand the impact of such integration.

show abstract